Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 weeks with ...

Clinical trials show weight loss between 15% to 21% for GLP-1s, but this study suggests that weight loss in the real world is ...

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

Around 1.5 million Brits are now taking weight-loss drugs, such as Mounjaro, and pharmacists are warning users to be careful in the heatwave ...

Experts and organizations call for stricter regulations on how such medications are prescribed – Side effect reports under ...

'Ozempic Penis' is the new side-effect that people have been turning their heads at, and users are reporting experiencing ...

She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.

It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and Orlistat.

A new study is showing the effectiveness of GLP-1 medication, commonly referred to as weight loss drugs, and how they stack ...

A WOMAN who went on Mounjaro to lose weight has been forced to quit after suffering horrendous hair loss. Carrie initially took to TikTok to bemoan how much her hair has thinned out since starting ...

Eli Lilly's Zepbound is the first and only approved dual GLP-1/GIP agonist, and Lilly is also working on its own triple ...